Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity

The management of the dysbiosed gut microbiota in inflammatory bowel diseases (IBD) is gaining more attention as a novel target to control this disease. Probiotic treatment with butyrate-producing bacteria has therapeutic potential since these bacteria are depleted in IBD patients and butyrate has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Geirnaert, Annelies, Calatayud, Marta, Grootaert, Charlotte, Laukens, Debby, Devriese, Sarah, Smagghe, Guy, De Vos, Martine, Boon, Nico, Van de Wiele, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597586/
https://www.ncbi.nlm.nih.gov/pubmed/28904372
http://dx.doi.org/10.1038/s41598-017-11734-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597586/
https://www.ncbi.nlm.nih.gov/pubmed/28904372
http://dx.doi.org/10.1038/s41598-017-11734-8

Ejemplares similares